Clinical Supply Management Articles

  1. How Clinical Supply Teams Pull Better Demand Signals 2/6/2026

    Clinical supply teams reduce risk by using site-level enrollment data, screen failure rates, and amendment impacts to guide material commitments and plan for uncertainty.

  2. Why Clinical Supply Risk Starts With Demand Signals 2/5/2026

    Clinical supply risk often begins long before manufacturing or distribution. Flawed demand signals and enrollment forecasts can quietly create shortages, delays, and costly material waste.

  3. Where Clinical Supply Chain Meets Humanity: Why It's Never "Just A Box" 1/27/2026

    Clinical supply chain decisions move more than inventory. They influence dignity, safety, and patient outcomes every day.

  4. Global Clinical Supply — Confronting Persistent Challenges With Strategic Action 1/21/2026

    From regulatory fragmentation to cold chain risks, discover how strategic action, data visibility, and resilient design keep clinical trials on track.

  5. Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity 1/16/2026

    Getting drugs and devices to the doorstep is only half the battle. When digital connections fail, trials fail. Why the digital last mile needs clinical supply ownership, human-centered design, and tech support with a bedside manner.

  6. Building A Culture Of Compliance In Clinical Supply 1/15/2026

    Build a resilient clinical supply operation by embedding export compliance into every process, from leadership to training, technology, and audits, turning regulatory adherence into a strategic advantage.

  7. Global Clinical Supply Chain in Emerging Markets: Reliability, Compliance, Access 1/13/2026

    Emerging markets hold 2.5B potential patients, yet trials stall on fragile supply chains. A design-first blueprint shows how reliability, compliance, and last-mile access unlock resilient, patient-centric delivery worldwide.

  8. Sales & Operations Planning for Small Teams: Aligning Clinical Supply 1/6/2026

    Small clinical teams don’t fail at S&OP from missing systems—they fail from unclear demand and decisions. Alignment comes from discipline, shared visibility, and acting on reality before timelines slip.

  9. Global Implications Of Zero Tariffs On Indian Pharma Exports To China 11/5/2025

    Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.

  10. Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development 10/21/2025

    Discover how partnerships — especially with capable CROs — as well as resilient supply chains, digital enablement, regulatory foresight, and specialized talent impact the success of targeted protein degradation therapies.